Author

Dominique N. Lisiero

Observed names: D. Lisiero, D. N. Lisiero, Dominique Lisiero, Dominique N Lisiero, Dominique Naomi Lisiero

Institutions: University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center

Observed institutions: University of Wisconsin–Madison, California NanoSystems Institute, University of California, Los Angeles, Ludwig Cancer Research, University of California San Diego, University of Wisconsin Carbone Cancer Center, Ludwig Cancer Research, Ludwig Cancer Research, Moores Cancer Center, UCLA Jonsson Comprehensive Cancer Center

OpenAlex ID: A5015815617

Photoexcited CRY2 Interacts with CIB1 to Regulate Transcription and Floral Initiation in Arabidopsis

2008 · Hongtao Liu, Xuhong Yu, et al. · Science · 711

An Essential Requirement for the SCAP/SREBP Signaling Axis to Protect Cancer Cells from Lipotoxicity

2013 · Kevin J. Williams, Joseph P. Argus, et al. · Cancer Research · 197

Comparison of Glioma-associated Antigen Peptide-loaded Versus Autologous Tumor Lysate-loaded Dendritic Cell Vaccination in Malignant Glioma Patients

2013 · Robert M. Prins, Xiaoyan Wang, et al. · Journal of Immunotherapy · 120

Monitoring of Regulatory T Cell Frequencies and Expression of CTLA-4 on T Cells, before and after DC Vaccination, Can Predict Survival in GBM Patients

2012 · Brendan Fong, Richard Jin, et al. · PLoS ONE · 108

PDF

The histone deacetylase inhibitor, LBH589, promotes the systemic cytokine and effector responses of adoptively transferred CD8+ T cells

2014 · Dominique N Lisiero, Horacio Soto, et al. · Journal for ImmunoTherapy of Cancer · 54

PDF

Efficacy of systemic adoptive transfer immunotherapy targeting NY-ESO-1 for glioblastoma

2015 · Richard G. Everson, Joseph P. Antonios, et al. · Neuro-Oncology · 43

PDF

Cytokine responsiveness of CD8+ T cells is a reproducible biomarker for the clinical efficacy of dendritic cell vaccination in glioblastoma patients

2014 · Richard G Everson, Richard M Jin, et al. · Journal for ImmunoTherapy of Cancer · 37

PDF

Enhanced Sensitivity to IL-2 Signaling Regulates the Clinical Responsiveness of IL-12–Primed CD8+ T Cells in a Melanoma Model

2011 · Dominique N Lisiero, Horacio Soto, et al. · The Journal of Immunology · 25

PDF

IκBα deficiency imposes a fetal phenotype to intestinal stem cells

2019 · Laura Marruecos, Joan Bertran, et al. · EMBO Reports · 19

PDF

IκBα Nuclear Export Enables 4-1BB–Induced cRel Activation and IL-2 Production to Promote CD8 T Cell Immunity

2020 · Dominique N Lisiero, Zhang Cheng, et al. · The Journal of Immunology · 13

Correction: Monitoring of Regulatory T Cell Frequencies and Expression of CTLA-4 on T Cells, before and after DC Vaccination, Can Predict Survival in GBM Patients

2012 · Brendan Fong, Richard Jin, et al. · PLoS ONE · 13

HAPLN1 confers multiple myeloma cell resistance to several classes of therapeutic drugs

2022 · Mailee Huynh, Hae Yeun Chang, et al. · PLoS ONE · 5

PDF

Correction: Monitoring of Regulatory T Cell Frequencies and Expression of CTLA-4 on T Cells, before and after DC Vaccination, Can Predict Survival in GBM Patients

2012 · Brendan Fong, Richard Jin, et al. · PLoS ONE · 5

PDF

Immunotherapy/biological Therapies

2013 · J. Campian, D. Gladstone, et al. · Neuro-Oncology · 3

PDF

IMMUNOTHERAPY

2011 · M. J. Hickey, C. K. Malone, et al. · Neuro-Oncology · 2

PDF

Nuclear export of NF-κB inhibitor, IκBα, is crucial for T cell function (IRM12P.644)

2015 · Dominique Lisiero, Melba Marie Tejera, et al. · The Journal of Immunology · 1

Clin-immunotherapy/biologic Therapies

2012 · I. F. Pollack, R. I. Jakacki, et al. · Neuro-Oncology · 1

PDF

NF-κB/RelA signaling required for CD40-induced humoral immunity depends on specific NEMO lysine residues in mice

2026 · Donna Li, Shelly M Wuerzberger-Davis, et al. · The EMBO Journal

PDF

Supplementary Table 1 from An Essential Requirement for the SCAP/SREBP Signaling Axis to Protect Cancer Cells from Lipotoxicity